IL-37 ameliorates experimental asthma by inhibiting IL-1

A. Schroeder (Borstel, Germany), L. Lunding (Borstel, Germany), C. Vock (Borstel, Germany), B. Schaub (Munich, Germany), U. Zissler (Munich, Germany), H. Fehrenbach (Borstel, Germany), M. Wegmann (Borstel, Germany)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1647
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Schroeder (Borstel, Germany), L. Lunding (Borstel, Germany), C. Vock (Borstel, Germany), B. Schaub (Munich, Germany), U. Zissler (Munich, Germany), H. Fehrenbach (Borstel, Germany), M. Wegmann (Borstel, Germany). IL-37 ameliorates experimental asthma by inhibiting IL-1. 1647

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: